These mitochondrial genetic changes may contribute to the age-dependent decrease in MOTS-c levels
Either of the injectibles should be injected subcutaneously (just under the skin), typically in the abdomen, thigh, or upper arm
Your hunger hormones (ghrelin) and satiety signals typically return to pre-treatment levels, making it easier to overeat if you haven't developed strong dietary habits during treatment
Comparison studies like SURPASS-2 have shown that tirzepatide (Mounjaro) often leads to faster and greater weight reduction because it targets two receptors (GLP-1 and GIP) instead of just one
I have provided some broad categories and a few names, but Im sure there are more (if you find a good one, please let me know)
Nevertheless, multiple alternative explanations for dental health changes during treatment should be considered before attributing causation to the medication itself